Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people barely feel the Wegovy needle at all. The pre-filled pen uses a very fine, short needle designed for subcutaneous (under-skin) injection, and clinical trial participants consistently rated injection-site discomfort as mild. That said, sensation varies: a few people notice a brief sting or pressure, and some feel almost nothing. Wegovy is a prescription-only medicine; a prescriber assesses whether it is clinically suitable before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial, published in the New England Journal of Medicine, randomised 1,961 adults over 68 weeks to weekly subcutaneous semaglutide 2.4mg or placebo. Injection-site reactions were reported by around 5% of participants on semaglutide and were almost entirely mild: transient redness, slight tenderness or minor bruising. Crucially, the trial did not identify injection discomfort as a reason for stopping treatment. That is meaningful. Hundreds of weekly injections were completed across thousands of participant-weeks, and the pen's design clearly kept the experience tolerable for the vast majority.
The NHS patient information for semaglutide lists injection-site reactions among the possible side effects but categorises them as common and generally not serious, consistent with the trial data. So the honest answer from the evidence is: most people tolerate Wegovy injections well, some notice very little, and a small number find the site briefly sore.
If you are comparing Wegovy to other weight-loss injections in terms of comfort, our guide to weight-loss injections covers the broader landscape.
The Wegovy pen is a pre-filled, pre-set device: the needle is already attached, the dose is fixed, and you simply place it against your skin and press. You do not see the needle extend or retract. That design is deliberate. Novo Nordisk's pen engineering keeps the needle short enough to sit in subcutaneous fat (the soft layer beneath your skin) rather than reaching muscle. Muscle injections hurt notably more; subcutaneous ones generally do not.
Gauge also matters. Fine-gauge needles displace less tissue and trigger fewer nerve endings. If you want a closer look at the physical dimensions before your first injection, our page on the Wegovy needle's size walks through exactly what you are working with.
Temperature plays a role too. Injecting a pen straight from the fridge is one of the most common causes of extra stinging — cold medicine entering the tissue produces more sensation than medicine at room temperature. The SmPC gives a specific window for how long the pen can safely sit out; check the Patient Information Leaflet inside your pack for the exact timing, as it is the authoritative source for your specific product batch.
Injection technique accounts for a large part of the variation in what people feel. The sites licensed for Wegovy are the abdomen (at least a few centimetres from the navel), the front of the thigh, or the upper arm. Rotating between sites each week matters both for comfort and to avoid the localised fatty lumps (lipohypertrophy) that develop when the same spot is used repeatedly. A numb or lumpy patch absorbs the medicine less predictably and can feel more uncomfortable.
A few practical steps consistently reduce sensation. Clean the site with an alcohol swab and let it dry fully before injecting, wet alcohol stings. Hold the pen firmly and perpendicular to the skin, press smoothly rather than jabbing, and keep it in place for the count recommended in the instructions to ensure full dose delivery. Releasing the pen too early is a common first-injection mistake and can mean the dose is incomplete.
If you find a particular site more sensitive, the thigh is often more forgiving than the abdomen for people with less subcutaneous fat in that area. Our more detailed breakdown of the Wegovy needle and injection experience goes further on site selection.
Brief stinging during or immediately after injection is normal. Mild redness that fades within an hour or two is also within the expected range. What warrants attention is a reaction that worsens rather than resolves: increasing swelling, a lump that grows or persists for more than a few days, or any sign of infection such as spreading warmth, pus or fever at the site. These are uncommon but should be reported to your prescriber or GP.
Separately, if you experience severe abdominal pain that radiates to your back, with or without vomiting, seek urgent medical advice. This is unrelated to the needle itself but is a symptom flagged by the MHRA in its Drug Safety Update guidance for GLP-1 medicines as a potential indicator of pancreatitis, which requires prompt assessment.
Needle anxiety that makes injections genuinely difficult is worth raising with your clinical team rather than pushing through alone. It is a question our prescribers hear regularly, and there are practical approaches that help. If you are wondering whether you can feel the Wegovy injection at all, and what sensations are typical, you can also read about whether the Wegovy needle hurts and what patients who found the first injection easier than they expected have to say on our page about not feeling the Wegovy injection.
Wegovy is a prescription-only medicine requiring clinical assessment before a prescriber decides it is appropriate for you. If you are considering it, check your eligibility with a free consultation at our GPhC-registered pharmacy, where a named prescriber reviews every application the same day it arrives.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.